Looking Beyond Novo Nordisk, High-Yield Pfizer Is a Bigger Contrarian Opportunity Dec 22, 2025 Life Science
Backed by Nvidia, Recursion Soars 11% Following Bullish Analyst Call and Clinical Trial Update Dec 17, 2025 Life Science, Technology
Immunome Soars 15% as Phase 3 Trial of Desmoid Tumor Drug Achieves Overwhelming Success Dec 15, 2025 Life Science